NURIA
GARCÍA MARCHENA
Profesora ayudante doctora
Instituto de Salud Carlos III
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Salud Carlos III (23)
2023
-
Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients
International Journal of Molecular Sciences, Vol. 24, Núm. 19
-
Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder
International journal of molecular sciences, Vol. 24, Núm. 11
-
Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder
International Journal of Molecular Sciences, Vol. 24, Núm. 2
-
Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder
International Journal of Molecular Sciences, Vol. 24, Núm. 21
-
Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders
Translational Psychiatry, Vol. 13, Núm. 1
2022
-
Plasma Amino Acid Concentrations in Patients with Alcohol and/or Cocaine Use Disorders and Their Association with Psychiatric Comorbidity and Sex
Biomedicines, Vol. 10, Núm. 5
-
Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders
Brain Sciences, Vol. 12, Núm. 5
-
Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder
Biomedicines, Vol. 10, Núm. 5
2021
-
Inflammatory factors and depression in substance use disorder
The Neuroscience of Depression: Genetics, Cell Biology, Neurology, Behavior, and Diet (Elsevier), pp. 149-160
-
Inflammatory factors and depression in substance use disorder
The Neuroscience of Depression, 1st Edition: Volume 1-2 (Elsevier), pp. V2-149-V2-160
-
Influence of gender and education on cocaine users in an outpatient cohort in Spain
Scientific Reports, Vol. 11, Núm. 1
-
Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder
Scientific Reports, Vol. 11, Núm. 1
-
Plasma concentrations of lysophosphatidic acid and autotaxin in abstinent patients with alcohol use disorder and comorbid liver disease
Biomedicines, Vol. 9, Núm. 9
2020
-
Abstinent patients with alcohol use disorders show an altered plasma cytokine profile: Identification of both interleukin 6 and interleukin 17A as potential biomarkers of consumption and comorbid liver and pancreatic diseases
Journal of Psychopharmacology, Vol. 34, Núm. 11, pp. 1250-1260
-
Cocaine-induced changes in CX3CL1 and inflammatory signaling pathways in the hippocampus: Association with IL1β
Neuropharmacology, Vol. 162
-
Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 102
-
Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients
Scientific Reports, Vol. 10, Núm. 1
-
Variation in chemokines plasma concentrations in primary care depressed patients associated with Internet-based cognitive-behavioral therapy
Scientific Reports, Vol. 10, Núm. 1
2019
2017
-
Plasma chemokines in patients with alcohol use disorders: Association of CCL11 (Eotaxin-1) with psychiatric comorbidity
Frontiers in Psychiatry, Vol. 7, Núm. JAN